Skip to main content

Articles

Page 5 of 70

  1. Despite intensive basic scientific, translational, and clinical efforts in the last decades, glioblastoma remains a devastating disease with a highly dismal prognosis. Apart from the implementation of temozolo...

    Authors: Leon Emanuel Schnöller, Daniel Piehlmaier, Peter Weber, Nikko Brix, Daniel Felix Fleischmann, Alexander Edward Nieto, Martin Selmansberger, Theresa Heider, Julia Hess, Maximilian Niyazi, Claus Belka, Kirsten Lauber, Kristian Unger and Michael Orth
    Citation: Radiation Oncology 2023 18:51
  2. Stereotactic body radio therapy (SBRT) has emerged as a standard treatment option for nonsurgical candidates with early-stage non-small cell lung cancer (NSCLC). Pathological proof is sometimes difficult to ob...

    Authors: Shaonan Fan, Qi Zhang, Jingyao Chen, Gang Chen, Jiangyi Zhu, Tingting Li, Han Xiao, Shisuo Du, Zhaochong Zeng and Jian He
    Citation: Radiation Oncology 2023 18:49
  3. The incidence of classic radiation-induced liver disease (cRILD) has been significantly reduced. However, non-classic radiation-induced liver disease (ncRILD) remains a major concern following radiotherapy in ...

    Authors: Jian-Xu Li, Rui-Jun Zhang, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ling He, Mei-Ying Long, Jian-Hong Zhong, Hai-Yan Lu, Hong-Mei Zhou, Bang-De Xiang and Shi-Xiong Liang
    Citation: Radiation Oncology 2023 18:48
  4. Lung cancer (LC) is associated with high mortality and poor quality of life (QoL). The disease as well as oncological treatments such as radiation and chemotherapy with adverse effects can impair the QoL of pa...

    Authors: Friedemann Schad, Diana Steinmann, Shiao Li Oei, Anja Thronicke and Christian Grah
    Citation: Radiation Oncology 2023 18:47
  5. This study retrospectively compared the clinical and toxicity outcomes for the cervical cancer of the MRI-guided two adaptive brachytherapy (IGABT) fractions versus one IGABT fraction in one application.

    Authors: Shanshan Song, Dongmei Han, Ning Zhang, Zhuang Mao, Xin Guo and Guanghui Cheng
    Citation: Radiation Oncology 2023 18:46
  6. Authors: Masanori Hirata, Kazuaki Yasui, Naofumi Oota, Hirofumi Ogawa, Tsuyoshi Onoe, Sayo Maki, Yusuke Ito, Kenji Hayashi, Hirofumi Asakura, Shigeyuki Murayama, Koichi Mitsuya, Shoichi Deguchi, Katsumasa Nakamura, Nakamasa Hayashi, Tetsuo Nishimura and Hideyuki Harada
    Citation: Radiation Oncology 2023 18:45

    The original article was published in Radiation Oncology 2022 17:213

  7. Soft tissue sarcomas (STS) are a relatively rare group of malignant tumors. Currently, there is very little published clinical data, especially in the context of curative multimodal therapy with image-guided, ...

    Authors: Hendrik Dapper, Christian Diehl, Carolin Knebel, Carolin Mogler, Kai Borm, Sophie Dobiasch, Stephanie E. Combs and Jan C. Peeken
    Citation: Radiation Oncology 2023 18:44
  8. Methylprednisolone is recommended as the front-line therapy for radiation-induced brain necrosis (RN) after radiotherapy for nasopharyngeal carcinoma. However, some patients fail to benefit from methylpredniso...

    Authors: Xiaohuang Zhuo, Huiying Zhao, Meiwei Chen, Youqing Mu, Yi Li, Jinhua Cai, Honghong Li, Yongteng Xu and Yamei Tang
    Citation: Radiation Oncology 2023 18:43
  9. Conventional treatment of pulmonary metastatic sarcoma primarily involves surgery, with systemic therapy added in select patients. However, broader applications of radiation therapy techniques have prompted in...

    Authors: Paulina M. Gutkin, Elizabeth Gore, John Charlson, John C. Neilson, Candice Johnstone, David M. King, Donald A. Hackbarth, Adam Wooldridge, Rajeev Mannem and Meena Bedi
    Citation: Radiation Oncology 2023 18:42
  10. To investigate the prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma (ESCC) treated with definitive (chemo)radiotherapy.

    Authors: Lianshuang Xia, Xiaoxu Li, Jie Zhu, Zhaisong Gao, Ju Zhang, Guangjie Yang and Zhenguang Wang
    Citation: Radiation Oncology 2023 18:41
  11. Radiotherapy (RT) destroys cancer cells and activates the immune system while suppressing the immunity of tumor-associated tissues, including the tumor microenvironment (TME). However, to date, no anti-tumor t...

    Authors: Yusaku Miyata, Etsuyo Ogo, Toshi Abe, Hideki Hirata, Naotake Tsuda, Kimio Ushijima, Akihiko Kawahara, Jun Akiba, Hitoshi Obara and Tatsuyuki Kakuma
    Citation: Radiation Oncology 2023 18:40
  12. To investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated with CyberKnife.

    Authors: Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda and Kojiro Suzuki
    Citation: Radiation Oncology 2023 18:39
  13. High-dose proton beam therapy (PBT) uses excellent dose concentricity based on the unique characteristic termed the Bragg peak. PBT is a highly feasible treatment option that improves survival in select patien...

    Authors: Masahide Matsuda, Masashi Mizumoto, Hidehiro Kohzuki, Narushi Sugii, Hideyuki Sakurai and Eiichi Ishikawa
    Citation: Radiation Oncology 2023 18:38
  14. Glioblastoma (GBM) cellularity correlates with whole brain spectroscopic MRI (sMRI) generated relative choline to N-Acetyl-Aspartate ratio (rChoNAA) mapping. In recurrent GBM (rGBM), tumor volume (TV) delineation...

    Authors: Jonathan B. Bell, William Jin, Mohammed Z. Goryawala, Gregory A. Azzam, Matthew C. Abramowitz, Tejan Diwanji, Michael E. Ivan, Maria del Pilar Guillermo Prieto Eibl, Macarena I. de la Fuente and Eric A. Mellon
    Citation: Radiation Oncology 2023 18:37
  15. Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high local control rate with low symptomatic toxicities. Recently, Dynamic...

    Authors: Emmanuel Mesny, Myriam Ayadi, Pauline Dupuis, Guillaume Beldjoudi, Ronan Tanguy and Isabelle Martel-Lafay
    Citation: Radiation Oncology 2023 18:36
  16. To evaluate prognosis for reducing postoperative radiotherapy (PORT) dose to lymph node levels of supraglottic cancer (SC) on real-world data.

    Authors: Yi Xu, Yumei Wei, Jingbo Wang, Jianghu Zhang, Xuesong Chen, Runye Wu, Qingfeng Liu, Yuan Qu, Kai Wang, Xiaodong Huang, Jingwei Luo, Wei Xu, Ye Zhang and Junlin Yi
    Citation: Radiation Oncology 2023 18:35
  17. Daily adaptive radiation therapy (ART) of patients with non-small cell lung cancer (NSCLC) lowers organs at risk exposure while maintaining the planning target volume (PTV) coverage. Thus, ART allows an isotox...

    Authors: Lea Hoppen, Gustavo R. Sarria, Chung S. Kwok, Judit Boda-Heggemann, Daniel Buergy, Michael Ehmann, Frank A. Giordano and Jens Fleckenstein
    Citation: Radiation Oncology 2023 18:34
  18. This study inventively combines epidermal growth factor receptor (EGFR) expression of the primary lesion and standardized uptake value (SUV) of positron emission tomography and computed tomography (PET/CT) to ...

    Authors: Zhaodong Fei, Ting Xu, Huiling Hong, Yiying Xu, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Jing Liu and Chuanben Chen
    Citation: Radiation Oncology 2023 18:33
  19. To assess whether the high metabolic region of fluorine-18-fluorode-oxyglucose (18F-FDG) in the primary lesion is the crux for recurrence in patients with nasopharyngeal carcinoma (NPC), to assess the feasibility...

    Authors: Ting Xu, Ye Feng, Huiling Hong, Yiying Xu, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Chuanben Chen and Zhaodong Fei
    Citation: Radiation Oncology 2023 18:32
  20. This study aimed to evaluate and conduct a meta-analysis on the efficacy and safety of proton beam therapy (PBT) for rhabdomyosarcoma (RMS).

    Authors: Meng Dong, Jianrong Wu, Renhua Wu, Dandan Wang, Ruifeng Liu, Hongtao Luo, Yuhang Wang, Junru Chen, Yuhong Ou, Qiuning Zhang and Xiaohu Wang
    Citation: Radiation Oncology 2023 18:31
  21. The main challenge in follow-up duration of patients with brain metastases after stereotactic radiotherapy is to distinguish between pseudo-progression and tumor recurrence. The objective of this study is to r...

    Authors: Siran Yang, Yuchao Ma, Yingjie Xu, Qingfeng Liu, Ye Zhang, Xiaodong Huang, Xuesong Chen, Kai Wang, Ruizhi Zhao, Jianping Xiao and Hongmei Zhang
    Citation: Radiation Oncology 2023 18:30
  22. High-grade gliomas are the most common intracranial malignancies, and their current prognosis remains poor despite standard aggressive therapy. Charged particle beams have unique physical and biological proper...

    Authors: Yuhang Wang, Ruifeng Liu, Qiuning Zhang, Meng Dong, Dandan Wang, Junru Chen, Yuhong Ou, Hongtao Luo, Kehu Yang and Xiaohu Wang
    Citation: Radiation Oncology 2023 18:29
  23. Comparative prospective data regarding different radiosurgery (SRS) modalities for treating brain metastases (BMs) from solid tumors are not available. To investigate with a single institute phase III randomiz...

    Authors: Marta Scorsetti, Pierina Navarria, Luca Cozzi, Elena Clerici, Luisa Bellu, Davide Franceschini, Antonio Marco Marzo, Ciro Franzese, Valter Torri, Giacomo Reggiori, Francesca Lobefalo, Luca Raspagliesi, Luca Attuati, Federico Pessina, Andrea Franzini, Piero Picozzi…
    Citation: Radiation Oncology 2023 18:28
  24. Integrating magnetic resonance (MR) into radiotherapy planning has several advantages. This report details the clinical implementation of an MR simulation (MR-planning) program for external beam radiotherapy (...

    Authors: Daniel Moore-Palhares, Ling Ho, Lin Lu, Brige Chugh, Danny Vesprini, Irene Karam, Hany Soliman, Sean Symons, Eric Leung, Andrew Loblaw, Sten Myrehaug, Greg Stanisz, Arjun Sahgal and Gregory J. Czarnota
    Citation: Radiation Oncology 2023 18:27
  25. To compare the efficacy and safety of postoperative extensive target volume irradiation with elevated radiation dose and concurrent chemotherapy with radiotherapy only for the postoperative treatment of esopha...

    Authors: Dashan Ai, Yun Chen, Qi Liu, Jiaying Deng, Xiaofei Zhang, Junhua Zhang, Li Chu, Jingyi Shen, Longfei Ma, Yawei Zhang, Haiquan Chen, Longsheng Miao, Kuaile Zhao and Jiaqing Xiang
    Citation: Radiation Oncology 2023 18:26
  26. The Graded Prognostic Assessment for lung cancer using molecular markers (Lung-molGPA) has not been validated for use with Japanese non-small cell lung cancer (NSCLC) patients with brain metastasis (BM) and th...

    Authors: Hajime Higaki, Kentaro Nishioka, Manami Otsuka, Noboru Nishikawa, Motoyasu Shido, Hideki Minatogawa, Yukiko Nishikawa, Rikiya Takashina, Takayuki Hashimoto, Norio Katoh, Hiroshi Taguchi, Rumiko Kinoshita, Koichi Yasuda, Takashi Mori, Yusuke Uchinami, Fuki Koizumi…
    Citation: Radiation Oncology 2023 18:25
  27. Multiparametric imaging has been seen as a route to improved prediction of chemoradiotherapy treatment outcomes. Four-dimensional volumetric perfusion CT (4D PCT) is useful for whole-organ perfusion measuremen...

    Authors: Hirokazu Tsuchiya, Munetaka Matoba, Yuka Nishino, Kiyotaka Ota, Mariko Doai, Hiroji Nagata and Hiroyuki Tuji
    Citation: Radiation Oncology 2023 18:24
  28. To explore the dosimetric difference between IMRT-VB plan based on the establishment of external expansion structure and virtual bolus (VB) and IMRT-SF based on the skin flash (SF) tool of the Eclipse treatmen...

    Authors: Ran Tang, Aimin Li, Yingjing Li, Guanhua Deng, Yufeng Wang, Qing Xiao, Luosheng Zhang and Yue Luo
    Citation: Radiation Oncology 2023 18:23
  29. Approximately 20% of all cancer patients will develop brain metastases in their lifespan. The standard of care for patients with multiple brain metastases is whole-brain radiation therapy, which disrupts the b...

    Authors: K. E. Blethen, S. A. Sprowls, T. A. Arsiwala, C. P. Wolford, D. M. Panchal, R. A. Fladeland, M. J. Glass, L. P. Dykstra, B. N. Kielkowski, J. R. Blackburn, C. J. Andrick and P. R. Lockman
    Citation: Radiation Oncology 2023 18:22
  30. Brain metastases (BMs) are the leading cause of intracranial malignant neoplasms in adults. WHO, Karnofsky performance status (KPS), age, number of BMs, extracerebral progression (ECP), recursive partitioning ...

    Authors: L. Kuntz, C. Le Fèvre, D. Jarnet, A. Keller, P. Meyer, A. Thiery, H. Cebula, G. Noel and D. Antoni
    Citation: Radiation Oncology 2023 18:21
  31. The incidence of head and neck cancers (HNC) is rising worldwide especially with HPV-related oropharynx squamous cell carcinoma. The standard of care for the majority of patients with locally advanced pharynge...

    Authors: Tai Ermongkonchai, Richard Khor, Morikatsu Wada, Eddie Lau, Daniel Tao Xing and Sweet Ping Ng
    Citation: Radiation Oncology 2023 18:20
  32. The gene of the Epidermal growth factor receptor (EGFR) is one of the most frequently altered genes in glioblastoma (GBM), with deletions of exons 2–7 (EGFRvIII) being amongst the most common genomic mutations. E...

    Authors: Meryem H. Cetin, Thorsten Rieckmann, Konstantin Hoffer, Britta Riepen, Sabrina Christiansen, Fruzsina Gatzemeier, Simon Feyerabend, Melanie Schoof, Ulrich Schüller, Cordula Petersen, Martin Mynarek, Kai Rothkamm, Malte Kriegs and Nina Struve
    Citation: Radiation Oncology 2023 18:19
  33. This multicenter study aimed to explore the efficacy and toxicity of radioactive Iodine-125 seed implantation for lymph node recurrence in patients with esophageal cancer after external radiotherapy.

    Authors: Lirong Wu, Xinxin Zhao, Suqing Tian, Kaixian Zhang, Chuang He, Yong Feng, Jiawei Zhou, Wenjie Guo, Zhe Ji, Xia He, Guanglie Chen and Junjie Wang
    Citation: Radiation Oncology 2023 18:18
  34. Results from Lung ART and PORT-C trials suggest that postoperative radiotherapy (PORT) cannot routinely be recommended as standard treatment in completely resected pIIIA-N2 NSCLC patients, but their effects on...

    Authors: Shujie Zhou, Yirui Zhai, Kaikai Zhao, Yu Men, Xiangjiao Meng and Zhouguang Hui
    Citation: Radiation Oncology 2023 18:17
  35. Radiation therapy is the cornerstone of treatment for adult-type diffuse gliomas, but recurrences are inevitable. Our study assessed the prognosis and recurrence pattern of different radiotherapy volumes after...

    Authors: Hongbo Liu, Lu Zhang, Ye Tan, Yanxia Jiang and Haijun Lu
    Citation: Radiation Oncology 2023 18:16
  36. The high heterogeneity of de novo metastatic nasopharyngeal carcinoma (dmNPC) makes its prognosis and treatment challenging. We aimed to accurately stage dmNPC and assess the patterns of treatment strategies f...

    Authors: Yuyi Yao, Xuesong Sun, Huageng Huang, Zhao Wang, Xiaojie Fang, Meiting Chen, Zegeng Chen, Huawei Weng, Chengcheng Guo, Huangming Hong, He Huang and Tongyu Lin
    Citation: Radiation Oncology 2023 18:15
  37. To systematically evaluate the guidelines for the diagnosis and treatment of radioactive enteritis, compare their differences and reasons and provide some reference for updating them.

    Authors: Xiao-Feng Yang, Meng-Yao Zheng, Li-Ya An, Jin-Min Sun, Qian-Wen Hei, Yan-Hong Ji, Da-Li Sun and Hai-Yu He
    Citation: Radiation Oncology 2023 18:14
  38. The purpose of this study is to verify the correlation between medium and low radiation doses of the pelvic-bone marrow and the incidence of lymphocytic toxicity during concurrent chemoradiotherapy for cervica...

    Authors: Bao-Zhong Zhang, Yang Li, Li-Ming Xu, Yan-Lan Chai, Chao Qu, Yuan-Jie Cao, Jing Wang, Hai-Ling Hou and Jiaqi Zhang
    Citation: Radiation Oncology 2023 18:12
  39. Radiation dermatitis is a major concern in intensity modulated proton therapy (IMPT) for head and neck cancer (HNC) despite its demonstrated superiority over contemporary photon radiotherapy. In this study, do...

    Authors: Noufal Manthala Padannayil, Dayananda Shamurailatpam Sharma, Sapna Nangia, Kartikeshwar C. Patro, Utpal Gaikwad and Nagarjuna Burela
    Citation: Radiation Oncology 2023 18:11
  40. The limitation of cancer radiotherapy does not derive from an inability to ablate tumor, but rather to do so without excessively damaging critical tissues and organs and adversely affecting patient’s quality o...

    Authors: Jae Ho Kim, Stephen L. Brown and Marcia N. Gordon
    Citation: Radiation Oncology 2023 18:10
  41. To investigate the geometric and dosimetric impacts of intra-fractional movement for patients with single or multiple brain metastasis treated using Varian Hyperarc™ mono-isocentric radiosurgery.

    Authors: Nelson Tsz Cheong Fung, Wai Lung Wong, Michael Chi Hang Lee, Elki Sze Nga Cheung and Philip Yuguang Wu
    Citation: Radiation Oncology 2023 18:9
  42. Stereotactic radiotherapy (SRT) and hypo-fractionated radiotherapy are feasible treatment options for single glioblastoma multiforme when combined with conventional radiotherapy or delivered alone. HyperArc (H...

    Authors: Mingyuan Pan, Wenqian Xu, Lei Sun, Chaozhuang Wang, Shengnan Dong, Yun Guan, Jun Yang and Enmin Wang
    Citation: Radiation Oncology 2023 18:8
  43. Stereotactic radiation therapy (SRT) is a focal treatment for brain metastases (BMs); thus, 20 to 40% of patients will require salvage treatment after an initial SRT session, either because of local or distant...

    Authors: L. Kuntz, C. Le Fèvre, D. Jarnet, A. Keller, P. Meyer, A. Thiery, H. Cebula, G. Noel and D. Antoni
    Citation: Radiation Oncology 2023 18:7
  44. CT ventilation image (CTVI)-guided radiotherapy that selectively avoids irradiating highly-functional lung regions has potential to reduce pulmonary toxicity. Considering Helical TomoTherapy (HT) has higher mo...

    Authors: Shuangshuang Li, Juan Liu, Shanbao Gao, Yicai Yin, Ling Zhang, Yongchao Han, Xishun Zhang, Yuanyuan Li, Jing Yan and Zhen Hou
    Citation: Radiation Oncology 2023 18:6
  45. The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related qualit...

    Authors: Eva Meixner, Antje Wark, Tobias Forster, Fabian Weykamp, Kristin Lang, Laila König, Katja Lindel, Jan Tobias Oelmann-Avendano, Johannes Krisam, Andreas Schneeweiss, Malte Ellerbrock, Thomas Mielke, Juliane Hörner-Rieber, Klaus Herfarth, Jürgen Debus and Nathalie Arians
    Citation: Radiation Oncology 2023 18:5
  46. Mesorectal motion (MM) is a source of uncertainty during neoadjuvant chemoradiotherapy (nCRT) delivery for locally advanced rectal cancer (LARC). Previously published experiences using cone-beam computed tomog...

    Authors: Luca Boldrini, Giuditta Chiloiro, Davide Cusumano, Angela Romano, Lorenzo Placidi, Gabriele Turco, Marco Valerio Antonelli, Matteo Nardini, Matteo Galetto, Luca Indovina and Maria Antonietta Gambacorta
    Citation: Radiation Oncology 2023 18:4
  47. Anatomical variations existing in cervical cancer radiotherapy treatment can be monitored by cone-beam computed tomography (CBCT) images. Deformable image registration (DIR) from planning CT (pCT) to CBCT imag...

    Authors: Yankui Chang, Yongguang Liang, Bo Yang, Jie Qiu, Xi Pei and Xie George Xu
    Citation: Radiation Oncology 2023 18:3
  48. Stereotactic radiosurgery (SRS) is the preferred treatment for vestibular schwannoma (VS) in patients with preserved hearing and tumour diameter < 3 cm. Emerging evidence suggests restricting cochlear dose cou...

    Authors: Jeremy Khong, Ramkumar Govindaraj, Daniel Ramm, Suzanne Edwards and Daniel Roos
    Citation: Radiation Oncology 2023 18:2
  49. Perirectal spacers may be beneficial to reduce rectal side effects from radiotherapy (RT). Here, we present the impact of a hyaluronic acid (HA) perirectal spacer on rectal dose as well as spacer stability, lo...

    Authors: Ulrika Björeland, Kristina Notstam, Per Fransson, Karin Söderkvist, Lars Beckman, Joakim Jonsson, Tufve Nyholm, Anders Widmark and Camilla Thellenberg Karlsson
    Citation: Radiation Oncology 2023 18:1

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions